Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2016

Sep 9, 2016

30786_dirs_2016-09-09_9007cad3-b429-46f2-bbd6-2e57ea58db1e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-09-07

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-09-07 Restricted Stock Units $0 A 15000 Acquired Bio-Rad B Common Stock (15000) Direct
2016-09-07 Non-Qualified Stock Option (right to buy) $159.32 A 15000 Acquired 2026-09-07 Bio-Rad B Common Stock (15000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 411252 Direct
Bio-Rad B Common Stock 197763 Direct
Bio-Rad B Common Stock 12586 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 13726 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: The shares are held by a limited partnership of which the reporting person is a limited partner.

F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.

F5: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F6: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.